US Patent 12077802 Metabolic engineering of
Patent 12077802 was granted and assigned to InMed Pharmaceuticals on September, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12077802 Metabolic engineering of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
